An iatrogenic pandemic of panic

British Medical Journal

Volumn 332, Issue 7544, 2006, Pages 786-788

  Bonneux, Luc ^a   Van Damme, Wim ^b  

^a Institute of Tropical Medicine ^*

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIOXIN; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR; ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AVIAN INFLUENZA; DRUG COST; DRUG MANUFACTURE; EPIDEMIC; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IATROGENIC DISEASE; INFLUENZA; INFLUENZA VIRUS A; MEDICAL ETHICS; PANDEMIC; PANIC; PRIORITY JOURNAL; PUBLIC OPINION; VIRUS HEMORRHAGIC FEVER; ATTITUDE TO HEALTH; ECONOMICS; INTERNATIONAL COOPERATION; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR;

ANTIVIRAL AGENTS; ATTITUDE TO HEALTH; DISEASE OUTBREAKS; DRUG COSTS; HUMANS; INFLUENZA, HUMAN; INTERNATIONAL COOPERATION; PANIC; RISK FACTORS;

EID: 33645561447     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7544.786     Document Type: Article

References (19)

1. Boersema D. Vogeigriep leidt tot run op virusremmer via website [Bird flu causes run for antivirals through website]. Volkskrant 2005 Oct 20.
2. CNN. Bird flu may kill 150m, warns UN, 30 September 2005. www.cnn.com/2005/WORLD/asiapcf/09/29/birdflu.un/ (accessed 13 Mar 2005).
3. Bernard A, Hermans C, Broeckaert F, De Poorter G, De Cock A, Houins G. Food contamination by PCBs and dioxins. Nature 1999;401:231-2.
4. Bellaby P. Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination. BMJ 2003;327:725-8.
5. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997;87:1944-50.
6. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;178:53-60.
7. Centers for Disease Control and Prevention. Spread of avian influenza viruses among birds. www.cdc.gov/flu/avian/gen-info/spread.htm (accessed 13 Mar 2006).
8. Macfarlane JT, Lim WS. Bird flu and pandemic flu. BMJ 2005;331:975-6.
9. Beveridge WI. The chronicle of influenza epidemics. Hist Philos Life Sci 1991;13:223-34.
10. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000;355:827-35.
11. Dolin R. Influenza. In: Harrison's Principles of Internal Medicine. 15th ed. McGraw-Hill, New York, 2001:1125-30.
12. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235.
13. National Institute for Health and Clinical Excellence. Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. Technology appraisal No 58. www.nice.org.uk/pdf/58_Flu_fullguidance.pdf (accessed 13 Mar 2006).
14. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivelti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367:303-13.
15. Moynihan R, Cassels A. Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients. Berkley, CA: Greystone Books, 2005.
16. Lokuge B, Drahos P, Neville W. Pandemics, antiviral stockpiles and biosecurity in Australia: what about the generic option? Med J Aust 2006;184:16-20.
17. Barton JH, Emanuel FJ. The patents-based pharmaceutical development process: rationale, problems, and potential reforms. JAMA 2005;294:2075-82.
18. Van Damme W, Van Lerberghe W. Strengthening health services to control epidemics: empirical evidence from Guinea on its cost-effectiveness. Trop Med Int Health 2004;9:281-91.
19. Van Damme W, Van Lerberghe W. Epidemics and fear. Trop Med Int Health 2000;5:511-4.